These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33908358)

  • 21. Current advances in the development of SARS-CoV-2 vaccines.
    Awadasseid A; Wu Y; Tanaka Y; Zhang W
    Int J Biol Sci; 2021; 17(1):8-19. PubMed ID: 33390829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double standards redux.
    Macklin R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WHO guidance on COVID-19 vaccine trial designs in the context of authorized COVID-19 vaccines and expanding global access: Ethical considerations.
    Singh JA; Kochhar S; Wolff J; Atuire C; Bhan A; Emanuel E; Faden R; Ghimire P; Greco D; Ho C; Moon S; Shamsi-Gooshki E; Touré A; Thomé B; Smith MJ; Upshur REG
    Vaccine; 2022 Mar; 40(14):2140-2149. PubMed ID: 35248422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethical guidelines for deliberately infecting volunteers with COVID-19.
    Richards AD
    J Med Ethics; 2020 Aug; 46(8):502-504. PubMed ID: 32461245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates.
    Berry DA; Berry S; Hale P; Isakov L; Lo AW; Siah KW; Wong CH
    PLoS One; 2020; 15(12):e0244418. PubMed ID: 33362278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward.
    Iserson KV
    Camb Q Healthc Ethics; 2021 Jan; 30(1):59-68. PubMed ID: 32498742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintaining a Focus on Health Equity During the COVID-19 Vaccine Rollout.
    Martin EG; Birkhead GS; Holtgrave DR
    J Public Health Manag Pract; 2021 May-Jun 01; 27(3):226-228. PubMed ID: 33762538
    [No Abstract]   [Full Text] [Related]  

  • 28. Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia.
    Holm S
    J Med Ethics; 2020 Sep; 46(9):569-573. PubMed ID: 32616623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Running with the devil: race against COVID-19.
    Memo C
    J Wound Care; 2021 Jan; 30(1):7-8. PubMed ID: 33439088
    [No Abstract]   [Full Text] [Related]  

  • 30. Covid-19: Chinese vaccines may need changes to improve efficacy, admits official.
    Dyer O
    BMJ; 2021 Apr; 373():n969. PubMed ID: 33849893
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19 vaccine trials with children: ethics pointers.
    Atuire CA; Salas SP; Wright K; Ambe JR; de Vries J
    BMJ Glob Health; 2022 Jan; 7(1):. PubMed ID: 35012971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies.
    Steuwer B; Jamrozik E; Eyal N
    Int J Infect Dis; 2021 Apr; 105():307-311. PubMed ID: 33592338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2020 race towards SARS-CoV-2 specific vaccines.
    Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
    Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    Rid A; Lipsitch M; Miller FG
    JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
    Al-Kassmy J; Pedersen J; Kobinger G
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.
    Xia S; Zhang Y; Wang Y; Wang H; Yang Y; Gao GF; Tan W; Wu G; Xu M; Lou Z; Huang W; Xu W; Huang B; Wang H; Wang W; Zhang W; Li N; Xie Z; Ding L; You W; Zhao Y; Yang X; Liu Y; Wang Q; Huang L; Yang Y; Xu G; Luo B; Wang W; Liu P; Guo W; Yang X
    Lancet Infect Dis; 2021 Jan; 21(1):39-51. PubMed ID: 33069281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 vaccines: the importance of transparency and fact-based education.
    Cohen AF; van Gerven J; Burgos JG; de Boer A; Foucher RAM; Flore H; Teitelbaum Z; van Eden W; Webb A; Cremers S
    Br J Clin Pharmacol; 2020 Nov; 86(11):2107-2110. PubMed ID: 33464636
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccine trials during a pandemic: potential approaches to ethical dilemmas.
    Alqahtani M; Mallah SI; Stevenson N; Doherty S
    Trials; 2021 Sep; 22(1):628. PubMed ID: 34526086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Super-rapid race for saving lives by developing COVID-19 vaccines.
    Uttarilli A; Amalakanti S; Kommoju PR; Sharma S; Goyal P; Manjunath GK; Upadhayay V; Parveen A; Tandon R; Prasad KS; Dakal TC; Ben Shlomo I; Yousef M; Neerathilingam M; Kumar A
    J Integr Bioinform; 2021 Mar; 18(1):27-43. PubMed ID: 33761582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Dal-Ré R; Caplan AL; Gluud C; Porcher R
    Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.